Beijing SL Pharmaceutical Co Ltd (002038) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.012x

Based on the latest financial reports, Beijing SL Pharmaceutical Co Ltd (002038) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥66.55 Million ≈ $9.74 Million USD) by net assets (CN¥5.70 Billion ≈ $834.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002038 company net worth for the company's overall valuation and market capitalisation.

Beijing SL Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Beijing SL Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Beijing SL Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing SL Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Beijing SL Pharmaceutical Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
SUPERLOOP LTD
F:9SL
N/A
S.J.S. Enterprises Limited
NSE:SJS
0.122x
MFA Financial Inc
NYSE:MFA
0.073x
Mishra Dhatu Nigam Limited
NSE:MIDHANI
0.007x
Hedef Holdings AS
IS:HEDEF
0.025x
Aoyuan Beauty Valley Technology Co Ltd
SHE:000615
-0.002x
Power HF Co Ltd
SHG:605100
0.060x
BW OFFSHORE LTD. DL 050
F:XY81
0.083x

Annual Cash Flow Conversion Efficiency for Beijing SL Pharmaceutical Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Beijing SL Pharmaceutical Co Ltd from 2003 to 2025. View Beijing SL Pharmaceutical Co Ltd stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.19 Billion
≈ $759.25 Million
CN¥257.66 Million
≈ $37.70 Million
0.050x +22.90%
2024-12-31 CN¥5.58 Billion
≈ $816.62 Million
CN¥225.49 Million
≈ $33.00 Million
0.040x -48.99%
2023-12-31 CN¥5.81 Billion
≈ $850.19 Million
CN¥460.20 Million
≈ $67.34 Million
0.079x +11.33%
2022-12-31 CN¥5.48 Billion
≈ $801.78 Million
CN¥389.82 Million
≈ $57.04 Million
0.071x -18.44%
2021-12-31 CN¥5.33 Billion
≈ $779.39 Million
CN¥464.63 Million
≈ $67.99 Million
0.087x +4.57%
2020-12-31 CN¥4.98 Billion
≈ $729.42 Million
CN¥415.84 Million
≈ $60.85 Million
0.083x -39.59%
2019-12-31 CN¥4.82 Billion
≈ $705.49 Million
CN¥665.83 Million
≈ $97.43 Million
0.138x +28.62%
2018-12-31 CN¥4.52 Billion
≈ $661.20 Million
CN¥485.17 Million
≈ $71.00 Million
0.107x +21.25%
2017-12-31 CN¥4.30 Billion
≈ $629.14 Million
CN¥380.72 Million
≈ $55.71 Million
0.089x -12.31%
2016-12-31 CN¥3.93 Billion
≈ $575.09 Million
CN¥396.86 Million
≈ $58.07 Million
0.101x -27.73%
2015-12-31 CN¥3.61 Billion
≈ $528.73 Million
CN¥504.87 Million
≈ $73.88 Million
0.140x -4.41%
2014-12-31 CN¥3.18 Billion
≈ $465.50 Million
CN¥465.00 Million
≈ $68.04 Million
0.146x +8.93%
2013-12-31 CN¥2.59 Billion
≈ $378.85 Million
CN¥347.41 Million
≈ $50.84 Million
0.134x -28.91%
2012-12-31 CN¥2.11 Billion
≈ $308.98 Million
CN¥398.60 Million
≈ $58.33 Million
0.189x +39.20%
2011-12-31 CN¥1.69 Billion
≈ $246.66 Million
CN¥228.59 Million
≈ $33.45 Million
0.136x -31.02%
2010-12-31 CN¥1.21 Billion
≈ $177.26 Million
CN¥238.13 Million
≈ $34.85 Million
0.197x +10.81%
2009-12-31 CN¥983.06 Million
≈ $143.85 Million
CN¥174.41 Million
≈ $25.52 Million
0.177x -30.38%
2008-12-31 CN¥762.61 Million
≈ $111.59 Million
CN¥194.32 Million
≈ $28.44 Million
0.255x +59.16%
2007-12-31 CN¥551.93 Million
≈ $80.76 Million
CN¥88.36 Million
≈ $12.93 Million
0.160x +18.56%
2006-12-31 CN¥426.20 Million
≈ $62.37 Million
CN¥57.55 Million
≈ $8.42 Million
0.135x +8.78%
2005-12-31 CN¥382.49 Million
≈ $55.97 Million
CN¥47.48 Million
≈ $6.95 Million
0.124x +43.52%
2004-12-31 CN¥361.45 Million
≈ $52.89 Million
CN¥31.26 Million
≈ $4.57 Million
0.086x -67.43%
2003-12-31 CN¥115.05 Million
≈ $16.84 Million
CN¥30.55 Million
≈ $4.47 Million
0.266x --

About Beijing SL Pharmaceutical Co Ltd

SHE:002038 China Drug Manufacturers - Specialty & Generic
Market Cap
$844.87 Million
CN¥5.77 Billion CNY
Market Cap Rank
#9724 Global
#2514 in China
Share Price
CN¥5.62
Change (1 day)
+0.36%
52-Week Range
CN¥5.03 - CN¥8.98
All Time High
CN¥10151.79
About

Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, development, and production of genetic engineering and related drugs People's Republic of China and internationally. The company's finished formulations include temozolomide; arsenic trioxide; lenalidomide capsules; paclitaxel injection; docetaxel injection; thymopentin; vinorelbine tartrate injection; hydroxyl-camptothec… Read more